172 related articles for article (PubMed ID: 38523533)
1. Trajectory and magnitude of response in adults with anxiety disorders: a Bayesian hierarchical modeling meta-analysis of selective serotonin reuptake inhibitors, serotonin norepinephrine reuptake inhibitors, and benzodiazepines.
Mendez EM; Mills JA; Suresh V; Stimpfl JN; Strawn JR
CNS Spectr; 2024 Jun; 29(3):187-196. PubMed ID: 38523533
[TBL] [Abstract][Full Text] [Related]
2. The Impact of Antidepressant Dose and Class on Treatment Response in Pediatric Anxiety Disorders: A Meta-Analysis.
Strawn JR; Mills JA; Sauley BA; Welge JA
J Am Acad Child Adolesc Psychiatry; 2018 Apr; 57(4):235-244.e2. PubMed ID: 29588049
[TBL] [Abstract][Full Text] [Related]
3. Systematic review and meta-analysis: Dose-response curve of SSRIs and SNRIs in anxiety disorders.
Jakubovski E; Johnson JA; Nasir M; Müller-Vahl K; Bloch MH
Depress Anxiety; 2019 Mar; 36(3):198-212. PubMed ID: 30479005
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological treatments in panic disorder in adults: a network meta-analysis.
Guaiana G; Meader N; Barbui C; Davies SJ; Furukawa TA; Imai H; Dias S; Caldwell DM; Koesters M; Tajika A; Bighelli I; Pompoli A; Cipriani A; Dawson S; Robertson L
Cochrane Database Syst Rev; 2023 Nov; 11(11):CD012729. PubMed ID: 38014714
[TBL] [Abstract][Full Text] [Related]
5. Selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) for the prevention of migraine in adults.
Banzi R; Cusi C; Randazzo C; Sterzi R; Tedesco D; Moja L
Cochrane Database Syst Rev; 2015 Apr; 4(4):CD002919. PubMed ID: 25829028
[TBL] [Abstract][Full Text] [Related]
6. Advances in Pharmacotherapy for Pediatric Anxiety Disorders.
Nicotra CM; Strawn JR
Child Adolesc Psychiatr Clin N Am; 2023 Jul; 32(3):573-587. PubMed ID: 37201968
[TBL] [Abstract][Full Text] [Related]
7. Selective serotonin reuptake inhibitors, and serotonin and norepinephrine reuptake inhibitors for anxiety, obsessive-compulsive, and stress disorders: A 3-level network meta-analysis.
Gosmann NP; Costa MA; Jaeger MB; Motta LS; Frozi J; Spanemberg L; Manfro GG; Cuijpers P; Pine DS; Salum GA
PLoS Med; 2021 Jun; 18(6):e1003664. PubMed ID: 34111122
[TBL] [Abstract][Full Text] [Related]
8. Comparing the efficacy of benzodiazepines and serotonergic anti-depressants for adults with generalized anxiety disorder: a meta-analytic review.
Gomez AF; Barthel AL; Hofmann SG
Expert Opin Pharmacother; 2018 Jun; 19(8):883-894. PubMed ID: 29806492
[TBL] [Abstract][Full Text] [Related]
9. Antidepressant Tolerability in Pediatric Anxiety and Obsessive-Compulsive Disorders: A Bayesian Hierarchical Modeling Meta-analysis.
Mills JA; Strawn JR
J Am Acad Child Adolesc Psychiatry; 2020 Nov; 59(11):1240-1251. PubMed ID: 31682918
[TBL] [Abstract][Full Text] [Related]
10. The Impact of Development on Antidepressant and Placebo Response in Anxiety Disorders: A Bayesian Hierarchical Meta-Analytic Examination of Randomized Controlled Trials in Children, Adolescents, and Adults.
Mills JA; Mendez E; Strawn JR
J Child Adolesc Psychopharmacol; 2024 May; ():. PubMed ID: 38800869
[No Abstract] [Full Text] [Related]
11. Use of benzodiazepines and selective serotonin reuptake inhibitors in middle-aged and older adults with anxiety disorders: a longitudinal and prospective study.
Benítez CI; Smith K; Vasile RG; Rende R; Edelen MO; Keller MB
Am J Geriatr Psychiatry; 2008 Jan; 16(1):5-13. PubMed ID: 18165458
[TBL] [Abstract][Full Text] [Related]
12. Comparison of agomelatine and selective serotonin reuptake inhibitors/serotonin-norepinephrine reuptake inhibitors in major depressive disorder: A meta-analysis of head-to-head randomized clinical trials.
Huang KL; Lu WC; Wang YY; Hu GC; Lu CH; Lee WY; Hsu CC
Aust N Z J Psychiatry; 2014 Jul; 48(7):663-71. PubMed ID: 24604920
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and Safety of Selective Serotonin Reuptake Inhibitors, Serotonin-Norepinephrine Reuptake Inhibitors, and Placebo for Common Psychiatric Disorders Among Children and Adolescents: A Systematic Review and Meta-analysis.
Locher C; Koechlin H; Zion SR; Werner C; Pine DS; Kirsch I; Kessler RC; Kossowsky J
JAMA Psychiatry; 2017 Oct; 74(10):1011-1020. PubMed ID: 28854296
[TBL] [Abstract][Full Text] [Related]
14. Selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) for the prevention of tension-type headache in adults.
Banzi R; Cusi C; Randazzo C; Sterzi R; Tedesco D; Moja L
Cochrane Database Syst Rev; 2015 May; 2015(5):CD011681. PubMed ID: 25931277
[TBL] [Abstract][Full Text] [Related]
15. Current and Novel Psychopharmacological Drugs for Anxiety Disorders.
Bandelow B
Adv Exp Med Biol; 2020; 1191():347-365. PubMed ID: 32002937
[TBL] [Abstract][Full Text] [Related]
16. Pharmacologic predictors of benzodiazepine response trajectory in anxiety disorders: a Bayesian hierarchical modeling meta-analysis.
Stimpfl JN; Mills JA; Strawn JR
CNS Spectr; 2023 Feb; 28(1):53-60. PubMed ID: 34593077
[TBL] [Abstract][Full Text] [Related]
17. Pharmacotherapy for generalized anxiety disorder in adult and pediatric patients: an evidence-based treatment review.
Strawn JR; Geracioti L; Rajdev N; Clemenza K; Levine A
Expert Opin Pharmacother; 2018 Jul; 19(10):1057-1070. PubMed ID: 30056792
[TBL] [Abstract][Full Text] [Related]
18. Pharmacotherapy for social anxiety disorder (SAnD).
Williams T; Hattingh CJ; Kariuki CM; Tromp SA; van Balkom AJ; Ipser JC; Stein DJ
Cochrane Database Syst Rev; 2017 Oct; 10(10):CD001206. PubMed ID: 29048739
[TBL] [Abstract][Full Text] [Related]
19. Incidence of adverse events and comparative tolerability of selective serotonin reuptake inhibitors, and serotonin and norepinephrine reuptake inhibitors for the treatment of anxiety, obsessive-compulsive, and stress disorders: a systematic review and network meta-analysis.
Gosmann NP; Costa MA; Jaeger MB; Frozi J; Spanemberg L; Manfro GG; Cortese S; Cuijpers P; Pine DS; Salum GA
Psychol Med; 2023 Jul; 53(9):3783-3792. PubMed ID: 37278215
[TBL] [Abstract][Full Text] [Related]
20. The impact of antidepressants on seizure frequency and depressive and anxiety disorders of patients with epilepsy: Is it worth investigating?
Ribot R; Ouyang B; Kanner AM
Epilepsy Behav; 2017 May; 70(Pt A):5-9. PubMed ID: 28407526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
